Table 3.
Months | Proportion of Patient Nonpersistent with Treatment at Each Time Point N, % |
Curtin (n=284 380) | Lad (n=459 237) | Range (%) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Boluanger (n = 201) | Droege (n = 95) | Kruger Falk (n = 855) | Rasmussen 2013 (n = 555) | Rasmussen 2017 (n = 1027) | Subhi (n = 116) | Heimes (n = 191) | Holz (n = 2227) | Westborg (n = 932) | Ehlken 2018 (n=362) | ||||
6 | 174 094 (44.7) | ||||||||||||
12 | 37 (3.6) | 16 (13.8) | 532 (23.9) | 503 (50.8) | 68 (18.8) | 104 165 (53.6) | 213 645 (57.4) | 3.6–57.4 | |||||
18 | 112 647 (61.7) | 234 239 (65.6) | 61.7 – 65.6 | ||||||||||
24 | 10 (7.0) | 16 (13.8) | 60 (31.4) | 1043 (46.8) | 244 743 (71.0) | 7.0–71.0 | |||||||
36 | |||||||||||||
48 | 36 (4.2) | ||||||||||||
60 | 63 (31.3) | 60 (10.8) | 10.8–31.3 |